Who qualifies for the Vivimed Losartan settlement?

You qualify if you are an individual in the United States who paid any amount of money for retail purchases of Vivimed Losartan finished drug formulations sold under the specific impacted NDCs: 23155-644-09, 23155-644-10, 23155-645-03, 23155-645-09, 23155-645-10, 23155-646-03, 23155-646-09, and 23155-646-10. Check your pill bottle or pharmacy records for the NDC number.

How much can I get from the Vivimed Losartan settlement?

The total settlement fund is $1,899,000. After deductions for attorneys' fees (up to one-third), settlement administration costs, and service awards, the net fund will be distributed pro rata between consumers and third-party payors. Individual payouts depend on how much you paid for Vivimed Losartan and how many valid claims are filed.

Do I need proof to file a Vivimed Losartan settlement claim?

Documentation should be submitted to support your claim if possible. The notice says proof is encouraged but not strictly required. The settlement administrator may contact you for proof of purchase from your pharmacy if needed to approve your claim. Providing pharmacy receipts or records upfront will help prevent delays.

What was wrong with Vivimed Losartan?

The lawsuit alleges that certain batches of Vivimed Losartan were manufactured using active pharmaceutical ingredients contaminated with NMBA (N-nitroso-N-methyl-4-aminobutyric acid), a probable human carcinogen. These nitrosamine impurities were formed during the manufacturing process. Vivimed denies the contamination levels were harmful or carcinogenic.

When is the deadline to file a Vivimed Losartan settlement claim?

June 2, 2026. Claims can be submitted online at SartanMedicationSettlement.com or mailed to the settlement administrator. The same date is also the deadline to opt out or object.

Vivimed Losartan Class Action Settlement -- $1.899 Million for Contaminated Blood Pressure Drug

By Steve Levine

Vivimed Losartan Class Action Settlement $1.899 Million Contaminated Blood Pressure Drug NMBA Carcinogen 2026

Published: April 6, 2026

Claim Deadline: June 2, 2026

Settlement Fund: $1,899,000

Proof: Documentation encouraged, not strictly required

What Is This Settlement About?

Vivimed Life Sciences Pvt Ltd and Strides Pharma Science Limited (collectively, "Vivimed") have agreed to a $1,899,000 class action settlement to resolve economic loss claims that the company manufactured, distributed, and sold losartan blood pressure drugs contaminated with NMBA -- a probable human carcinogen. The settlement is part of a massive multidistrict litigation in the U.S. District Court for the District of New Jersey covering contamination in generic valsartan, losartan, and irbesartan blood pressure medications. It is one of three related settlements -- the largest being the $11.37 million Hetero Valsartan settlement for pills contaminated with NDMA.

The lawsuit alleges that Vivimed violated state laws by manufacturing and selling losartan finished drug formulations that contained NMBA (N-nitroso-N-methyl-4-aminobutyric acid), a nitrosamine impurity classified as a probable human carcinogen. The contamination was allegedly introduced during the manufacturing of the active pharmaceutical ingredient (API). The settlement also covers losartan repackaged by Heritage Pharmaceuticals Inc. (doing business as Avet Pharmaceuticals Inc.).

Vivimed denies all allegations of wrongdoing and denies that the NMBA levels in its losartan were harmful or carcinogenic. The company agreed to settle to avoid the cost and uncertainty of continued litigation.

This settlement resolves only the economic loss claims -- meaning what consumers and insurers overpaid for a drug that was allegedly defective. It does not cover personal injury or medical monitoring claims, which are being litigated separately in the same MDL.

Who Qualifies? Check Your NDC Number

You qualify if you are an individual in the United States who paid any amount of money for retail purchases of Vivimed losartan sold under one of these specific impacted National Drug Codes (NDCs):

• 23155-644-09
• 23155-644-10
• 23155-645-03
• 23155-645-09
• 23155-645-10
• 23155-646-03
• 23155-646-09
• 23155-646-10

The NDC number is printed on your pill bottle label and on your pharmacy receipt. If you still have an old bottle of losartan, check the label. If not, your pharmacy can look up your prescription history and tell you which manufacturer and NDC you received. Most major pharmacies (CVS, Walgreens, Rite Aid, Walmart, Kroger, Costco, independent pharmacies) can print your prescription history for free upon request.

The settlement covers both individual consumers and third-party payors (like health insurers and welfare funds). Excluded from the class are Vivimed itself, pharmacy benefit managers, and most federal and state government entities.

How Much Can I Get?

The total settlement fund is $1,899,000. Attorneys' fees (up to one-third, or ~$633,000), litigation costs, settlement administration expenses, and service awards to the named plaintiffs will be deducted before distribution. The net fund will then be allocated between consumers and third-party payors according to a plan approved by the court.

Individual payouts depend on how much you paid for Vivimed losartan during the class period and how many valid claims are filed. Payments will be made pro rata, meaning the more you spent, the larger your share. Because losartan is a long-term prescription for blood pressure management, people who took Vivimed losartan for months or years could see meaningful payouts.

Do I Need Proof?

The notice says documentation should be submitted if possible, but does not strictly require proof of purchase upfront. Here is what the settlement administrator will do:

• You file your claim form and describe your Vivimed losartan purchases.
• The administrator reviews your claim for fraud or mistaken claims.
• If your documentation is insufficient to approve the claim, the administrator may contact you for proof of purchase from your pharmacy.
• You then provide the requested documentation.

To prevent delays, it is best to include whatever proof you have with your initial claim. Acceptable documentation includes pharmacy receipts, prescription bottle labels showing the NDC, insurance explanation of benefits statements, or a pharmacy-printed prescription history. Your pharmacy can print your prescription history for free.

How Do I File a Claim?

Submit your claim online at SartanMedicationSettlement.com or download a paper claim form and mail it to the settlement administrator at:

Vivimed Settlement Notice Administrator
P.O. Box 3376
Baton Rouge, LA 70821

Your claim must be submitted online or postmarked by June 2, 2026.

This settlement is part of a broader group of three related settlements involving contaminated blood pressure drugs. If you also purchased Hetero valsartan (sold May -- July 2018) or Aurobindo irbesartan (sold January 2016 to present), you can file a claim for those settlements through the same website. See our combined blood pressure drug settlement page for details on all three.

When Will Payments Be Sent?

The final approval hearing is scheduled for June 30, 2026 at 10:00 AM at the U.S. District Court for the District of New Jersey. If the court grants final approval and no appeals are filed, the settlement administrator will begin distributing payments after the effective date. The exact timing depends on the court's final approval order and how long claims processing takes.

Case Information

Case: In re: Valsartan, Losartan, and Irbesartan Products Liability Litigation, Case No. 1:19-md-02875-RBK-SAK (MDL No. 2875)
Court: U.S. District Court, District of New Jersey
Judge: Hon. Renee M. Bumb
Defendants: Vivimed Life Sciences Pvt Ltd and Strides Pharma Science Limited
Also Covered: Losartan repackaged by Heritage Pharmaceuticals Inc. (d/b/a Avet Pharmaceuticals Inc.)
Settlement Fund: $1,899,000
Allegation: Losartan contaminated with NMBA, a probable human carcinogen, during manufacturing
Impacted NDCs: 23155-644-09, 23155-644-10, 23155-645-03, 23155-645-09, 23155-645-10, 23155-646-03, 23155-646-09, 23155-646-10
Who Qualifies: Individuals who paid any amount for Vivimed losartan under the impacted NDCs
Claim Deadline: June 2, 2026
Opt-Out Deadline: June 2, 2026
Objection Deadline: June 2, 2026
Final Approval Hearing: June 30, 2026 at 10:00 AM (D.N.J.)
Attorneys' Fees: Up to one-third of the fund (~$633,000)
Class Counsel: Slack Davis Sanger LLP, Honik Law, Kanner & Whiteley LLC
Class Representatives: Jacqueline Harris (Consumer) and MSP Recovery Claims Series LLC (TPP)
Settlement Website: SartanMedicationSettlement.com

How Do I Find Class Action Settlements?

Find all the latest class actions you can qualify for by getting notified of new lawsuits as soon as they are open to claims:

Official Settlement Notice (PDF)

Settlement Website: SartanMedicationSettlement.com

Submit Claim

Sources

• Official Settlement Website -- SartanMedicationSettlement.com
• Court-authorized Vivimed Settlement Notice, In re: Valsartan, Losartan, and Irbesartan Products Liability Litigation, Case No. 1:19-md-02875-RBK-SAK (D.N.J., filed Dec. 3, 2025)
• OpenClassActions -- Combined Valsartan, Losartan, Irbesartan Settlement Overview
• OpenClassActions -- Hetero Valsartan Settlement In-Depth Guide ($11.37M)
• OpenClassActions -- Aurobindo Irbesartan Settlement ($2M)

Filing Class Action Settlement Claims

Please note that your claim form will be rejected if you submit a settlement claim with any fraudulent information. By providing this information and your sworn statement of its veracity, you agree to do so under the penalty of perjury. If you are not sure whether you qualify, visit the class action administrator's website. OpenClassActions.com is a consumer advocacy and class action news site, and is not a class action administrator or a law firm.

For more class actions keep scrolling below.

Open Class Action Lawsuit and Class Action Settlement

DraftKings & FanDuel Addiction Lawsuits

Status: Open

Submit Claim

Kids Playing Roblox - Alleged Abuse

Pre-Qualify Here

Submit Claim

Social Media Addiction - Children

Status: Open

Pre-Qualify

File a rebate form to get a coupon, refund, rebate, or payment from this class action settlement

$4.17M RevitaLash Conditioner Settlement

Deadline: April 20, 2026

Submit Claim

$87.5M Beef Prices Settlement

Deadline: June 30, 2026

Submit Claim

Dollar General Bait & Switch Settlement

Deadline: April 13, 2026

Submit Claim

$2.9M Tom's of Maine Toothpaste Settlement

Deadline: July 6, 2026

Submit Claim

Acne Products Benzene Class Action Lawsuit

$990K Differin Acne Product Settlement

Deadline: May 19, 2026

Submit Claim

New Dog Supplements NO Proof Required Open Class Action Lawsuit

Cosequin Dog Supplements Settlement

Deadline: July 21, 2026

Submit Claim

New Open Class Action Lawsuit and Investigation

Depo Provera Investigation

Deadline: Pending

Pre-Qualify

Vivimed Losartan Settlement Summary
Status	Open — File Claim Now
Claim Deadline	June 2, 2026
Settlement Fund	$1,899,000
Drug	Vivimed Losartan (blood pressure)
Contaminant	NMBA (probable carcinogen)
Impacted NDCs	23155-644-09 – 23155-646-10
Final Hearing	June 30, 2026 (D.N.J.)
Website	Sartan Medication Settlement
Related	All 3 Settlements ($15.26M Combined) Hetero Valsartan Settlement ($11.37M) Aurobindo Irbesartan Settlement ($2M)